Markets

Health Care Sector Update for 01/19/2017: CATB

Top health-care stocks:

JNJ: +0.1%

PFE: -0.2%

ABT: -0.5%

MRK: -0.4%

AMGN: -0.1%

Health-care shares were mainly lower in early trade on Thursday.

In health-care stocks news, Catabasis Pharmaceuticals ( CATB ) has published Phase 1 data on edasalonexent in adult subjects, the company said Thursday. Edasalonexent is a potential disease-modifying therapy being developed for Duchenne muscular dystrophy (DMD).

Shares in the company were 19.1% higher at $5 in early trade. The stock has traded between $3.22 and $8.15 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CATB

Other Topics

US Markets